Home News Page 60

News

Goodwin Biotechnology and Aspyrian Therapeutics Collaborate on cGMP Manufacturing of a New Antibody Drug...

Goodwin Biotechnology, Inc. and Aspyrian Therapeutics, Inc. have entered in an agreement for the technology transfer, process development, scale-up,...

First Patients Enrolled In Phase I Trial with IGN523 for the Treatment of Acute...

Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the...

ProBioGen and Merus Agree on GlymaxX® ADCC Enhancement Technology

Two European companies, Germany (Berlin) based ProBioGen AG and The Netherlands (Utrecht) based Merus B.V. earlier today announced that they...

Meditope Biosciences Receives New Patent

Meditope Biosciences, Inc., a biotechnology company developing antibody-based products using its proprietary monoclonal antibody (mAb) technology platform, today announced receiving its...

University of Virginia Spin-off Neoantigenics Signs Agreement with Pfizer

Neoantigenics, a privately held oncology biotechnology company located in Charlottesville, established in July 2012 by John Herr at the University...

Meditope Biosciences Appoints Prominent Scientific Advisory Board

Meditope Biosciences, Inc., a biotechnology company developing antibody-based products, has appointed a number of inaugural members to its newly-formed...

Mersana Therapeutics Earns Second Milestone Payment in Fleximer-ADC Collaboration with Endo Pharmaceuticals

Mersana Therapeutics, Inc. announced today that it has achieved its second preclinical milestone in its collaboration with Endo Pharmaceuticals. In...

Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with AbbVie

Seattle Genetics today announced that it has further expanded its antibody-drug conjugate (ADC) collaboration with AbbVie. Under the expanded deal,...

Immunomedics Announces U.S. Patent for Antibody SN-38 Conjugates

Immunomedics Genetics a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of...

Sorrento Therapeutics Completes Acquisition of Concortis Biosystems

Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp. The transaction provides Sorrento...

FEATURED RESOURCES